Back to search
FDAFDA · Food and drugs·Recall number D-0771-2023

Tirzepatide 10 mg/0.5 mL Sterile Solution-2 mL Vial, Rx Only, For Sub-Q Use Only, Compounded Drug Product By: Revive Rx, 3831 Golf Dr A, Houston, TX 77018, NDC: 99000-9278-64.

Published May 31, 2023 · Recall initiated: May 11, 2023

Summary

FDA records drug Class II recall D-0771-2023, published May 31, 2023 and initiated May 11, 2023. Recalling firm: Revive Rx LLC dba Revive Rx Pharmacy; Status: Ongoing; Reported quantity: 45 Vials; Lot: Lot: 1643397 BUD: 10/16/2023. Class II means possible temporary or medically reversible effects, or a remote probability of serious health consequences.

Status when published: Ongoing — openFDA updates weekly, so this field may not reflect the current status. Always confirm with the official notice.

What's the hazard

Sub-potent Drug

What to do

Voluntary: Firm initiated · Letter

Get an email when a new FDA recall like this is published

Free. We only write when there's a new recall that matches. Unsubscribe in one click.

Recall details

Manufacturer
Revive Rx LLC dba Revive Rx Pharmacy
Distributor
Nationwide in the US
Lot
Lot: 1643397 BUD: 10/16/2023
Risk classification
Class II
Area (FDA)
drug
Country
United States

Related recalls

Questions about this recall

Was Tirzepatide 10 mg/0.5 mL Sterile Solution-2 mL Vial, Rx Only, For Sub-Q Use Only, Compounded Drug Product By: Revive Rx, 3831 Golf Dr A, Houston, TX 77018, NDC: 99000-9278-64. recalled?

Yes. FDA published recall D-0771-2023 on May 31, 2023. Reported hazard: Sub-potent Drug

What should I do if I have this product?

Voluntary: Firm initiated · Letter